BIOLASE (NASDAQ:BIOL) Now Covered by StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note published on Sunday morning. The brokerage issued a sell rating on the medical technology company’s stock.

BIOL has been the subject of several other reports. Benchmark reaffirmed a speculative buy rating and issued a $0.40 target price on shares of BIOLASE in a research report on Tuesday, May 14th. Maxim Group downgraded BIOLASE from a strong-buy rating to a hold rating in a research report on Friday, May 24th.

BIOLASE Trading Up 16.5 %

Shares of NASDAQ:BIOL opened at $0.09 on Friday. The business has a 50-day moving average price of $0.14 and a 200 day moving average price of $0.34. The company has a market capitalization of $3.00 million, a price-to-earnings ratio of -0.01 and a beta of 0.71. BIOLASE has a 12-month low of $0.04 and a 12-month high of $10.31.

BIOLASE (NASDAQ:BIOL) last released its earnings results on Monday, May 13th. The medical technology company reported ($0.36) earnings per share for the quarter. The firm had revenue of $10.13 million during the quarter. BIOLASE had a negative net margin of 43.56% and a negative return on equity of 1,782.73%.

Hedge Funds Weigh In On BIOLASE

An institutional investor recently raised its position in BIOLASE stock. Virtu Financial LLC grew its stake in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the quarter. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 as of its most recent filing with the SEC. Institutional investors own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.